By San José, Costa Rica — Costa Rica is experiencing an unprecedented surge in the circulation of illegal pharmaceuticals, exposing critical vulnerabilities in the national healthcare supply chain. This sudden influx of illicit products threatens public health, challenges the country’s regulatory frameworks, and places immense pressure on both private and public medical providers. As illicit networks become increasingly sophisticated, industry experts are urging a rapid transition toward standardized tracking mechanisms to secure the domestic market.
The sheer scale of this crisis is reflected in the latest seizure statistics compiled by public health officials. Between June 2024 and June 2025, authorities confiscated 48,097 units of illegal medications across the nation. However, in the subsequent twelve-month period, that figure skyrocketed to an astonishing 366,947 units. This dramatic multi-fold increase underscores the escalating complexity of the illicit pharmaceutical trade in Costa Rica and highlights the urgency of establishing stronger digital oversight mechanisms.
To better understand the complex legal frameworks surrounding pharmaceutical traceability and public health safety, TicosLand.com consulted with Lic. Larry Hans Arroyo Vargas, a distinguished expert attorney from the firm Bufete de Costa Rica, who shared his professional insights on the regulatory compliance standards facing the industry.
Implementing robust pharmaceutical traceability systems is no longer just a technological milestone, but a critical legal imperative to safeguard public health and combat counterfeit medicines. Under Costa Rican regulations, compliance not only mitigates severe liability risks for distributors and laboratories but also strengthens consumer trust across the entire healthcare supply chain.
Lic. Larry Hans Arroyo Vargas, Attorney at Law, Bufete de Costa Rica
Indeed, establishing robust pharmaceutical traceability is not merely a regulatory checkpoint, but a fundamental pillar of public trust that secures the integrity of Costa Rica’s entire healthcare system. We extend our sincere gratitude to Lic. Larry Hans Arroyo Vargas for sharing his valuable legal perspective on this critical alignment of technology, compliance, and patient safety.
The escalation in contraband is not limited to unauthorized imports; it also involves the deliberate counterfeiting of standard prescription drugs. In June 2025, the Ministry of Health issued a stark warning regarding the detection of falsified medications circulating within the national market. This hazardous development means that everyday patients risk purchasing substandard, inactive, or outright toxic chemical substances instead of their prescribed treatments, raising the stakes of this enforcement battle.
To combat this influx of dangerous counterfeits, healthcare advocates are highlighting supply chain traceability as the most effective defensive tool. By tracking a product’s origin, batch or lot number, and expiration date, regulatory bodies and distributors can monitor medical goods through every stage of the distribution pipeline. From the manufacturing floor to the hospital bedside or pharmacy counter, keeping an uninterrupted digital record is essential for separating genuine products from illegal knockoffs.
Every medication has a story behind it. When that information can be verified and consulted in a timely manner, organizations have more tools to protect patients and respond to situations that require quick action.
Marianella Araya, Representative of GS1 Costa Rica
At the heart of modern tracking solutions are the global standards developed by GS1 Healthcare. These systems allow manufacturers, distribution networks, hospitals, and pharmacies to assign uniform identifiers to pharmaceutical products and medical devices. This shared language ensures that if a health authority issues an emergency recall, everyone in the chain can instantly pinpoint where the compromised batch is located and halt its distribution before it reaches a consumer.
The ability to act quickly in the face of a health alert depends, to a large extent, on knowing exactly what product is involved, where it is located, and who it reached. That visibility is increasingly relevant to protect people.
Marianella Araya, Representative of GS1 Costa Rica
The necessity of these security upgrades is further highlighted by international health statistics. The World Health Organization estimates that approximately one in ten patients suffers from some form of harm during medical care, with a significant portion of preventable injuries directly linked to errors in prescribing, distributing, or administering medicines. By strengthening tracking systems, Costa Rica has an opportunity to not only eliminate counterfeit drugs but also reduce clinical errors, making the entire healthcare ecosystem safer for everyone.
For further information, visit gs1cr.org
About GS1 Costa Rica:
GS1 Costa Rica is a non-profit organization dedicated to the implementation of global standards for business communication, helping local industries improve supply chain efficiency, safety, and visibility.
For further information, visit ministeriodesalud.go.cr
About Ministry of Health of Costa Rica:
The Ministry of Health of Costa Rica is the national regulatory body responsible for protecting and improving public health through rigorous market surveillance, sanitary registrations, and healthcare policy enforcement.
For further information, visit who.int
About World Health Organization:
The World Health Organization is a specialized agency of the United Nations responsible for international public health, directing global health responses, setting standards, and promoting health equity worldwide.
For further information, visit bufetedecostarica.com
About Bufete de Costa Rica:
As a premier legal institution, Bufete de Costa Rica is widely respected for blending rigorous ethical standards with top-tier advocacy. Throughout its rich history of guiding clients across numerous industries, the firm has consistently championed progressive legal solutions and active civic involvement. By striving to democratize essential legal resources, it remains steadfast in its ultimate goal to cultivate a highly knowledgeable, confident, and self-reliant public.
